Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.

Abstract

The left ventricular (LV) remodeling process associated with significant valvular heart disease (VHD) is characterized by an increase of myocardial interstitial space with deposition of collagen and loss of myofibers. These changes occur before LV systolic function deteriorates or the patient develops symptoms. Cardiovascular magnetic resonance (CMR) permits assessment of reactive fibrosis, with the use of T1 mapping techniques, and replacement fibrosis, with the use of late gadolinium contrast enhancement. In addition, functional consequences of these structural changes can be evaluated with myocardial tagging and feature tracking CMR, which assess the active deformation (strain) of the LV myocardium. Several studies have demonstrated that CMR techniques may be more sensitive than the conventional measures (LV ejection fraction or LV dimensions) to detect these structural and functional changes in patients with severe left-sided VHD and have shown that myocardial fibrosis may not be reversible after valve surgery. More important, the presence of myocardial fibrosis has been associated with lesser improvement in clinical symptoms and recovery of LV systolic function. Whether assessment of myocardial fibrosis may better select the patients with severe left-sided VHD who may benefit from surgery in terms of LV function and clinical symptoms improvement needs to be demonstrated in prospective studies. The present review article summarizes the current status of CMR techniques to assess myocardial fibrosis and appraises the current evidence on the use of these techniques for risk stratification of patients with severe aortic stenosis or regurgitation and mitral regurgitation.

• Authors: Tomaz Podlesnikar, Victoria Delgado, Jeroen J Bax
• Journal: The international journal of cardiovascular imaging (Int J Cardiovasc Imaging) Vol. 34 Issue 1 Pg. 97-112 (Jan 2018) ISSN: 1875-8312 [Electronic] United States
• PMID: 28642994 (Publication Type: Journal Article, Review)

Chemical References

• Contrast Media

Topics

• Aortic Valve (diagnostic imaging, pathology, physiopathology)
• Aortic Valve Insufficiency (diagnostic imaging, pathology, physiopathology)
• Aortic Valve Stenosis (diagnostic imaging, pathology, physiopathology)
• Cardiomyopathies (diagnostic imaging, pathology, physiopathology)
• Contrast Media (administration & dosage)
• Fibrosis
• Humans
• Magnetic Resonance Imaging
• Mitral Valve (diagnostic imaging, pathology, physiopathology)
• Mitral Valve Insufficiency (diagnostic imaging, pathology, physiopathology)
• Myocardium (pathology)
• Predictive Value of Tests
• Prognosis
• Severity of Illness Index
• Stroke Volume
• Ventricular Function, Left
• Ventricular Remodeling